520 related articles for article (PubMed ID: 22463053)
1. Bactericidal antibody response against P6, protein D, and OMP26 of nontypeable Haemophilus influenzae after acute otitis media in otitis-prone children.
Khan MN; Kaur R; Pichichero ME
FEMS Immunol Med Microbiol; 2012 Aug; 65(3):439-47. PubMed ID: 22463053
[TBL] [Abstract][Full Text] [Related]
2. Antibody response to Haemophilus influenzae outer membrane protein D, P6, and OMP26 after nasopharyngeal colonization and acute otitis media in children.
Pichichero ME; Kaur R; Casey JR; Sabirov A; Khan MN; Almudevar A
Vaccine; 2010 Oct; 28(44):7184-92. PubMed ID: 20800701
[TBL] [Abstract][Full Text] [Related]
3. Serum antibody response to three non-typeable Haemophilus influenzae outer membrane proteins during acute otitis media and nasopharyngeal colonization in otitis prone and non-otitis prone children.
Kaur R; Casey JR; Pichichero ME
Vaccine; 2011 Jan; 29(5):1023-8. PubMed ID: 21129398
[TBL] [Abstract][Full Text] [Related]
4. Local and systemic antibody levels against protein D of Haemophilus influenzae following immunization and infection in rats.
Akkoyunlu M; Forsgren A
APMIS; 1996 Oct; 104(10):709-17. PubMed ID: 8980621
[TBL] [Abstract][Full Text] [Related]
5. Serum Concentrations of Antibodies against Outer Membrane Protein P6, Protein D, and T- and B-Cell Combined Antigenic Epitopes of Nontypeable Haemophilus influenzae in Children and Adults of Different Ages.
Hua CZ; Hu WL; Shang SQ; Li JP; Hong LQ; Yan J
Clin Vaccine Immunol; 2016 Feb; 23(2):155-61. PubMed ID: 26677200
[TBL] [Abstract][Full Text] [Related]
6. Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae.
Bertot GM; Becker PD; Guzmán CA; Grinstein S
J Infect Dis; 2004 Apr; 189(7):1304-12. PubMed ID: 15031801
[TBL] [Abstract][Full Text] [Related]
7. Antibody against Haemophilus influenzae protein D in patients with chronic conditions causing secondary immunodeficiency.
Hawdon N; Biman B; McCready W; Brigden M; Malik S; Vergidis D; Kisselgoff O; Ulanova M
Vaccine; 2012 Feb; 30(7):1235-8. PubMed ID: 22230580
[TBL] [Abstract][Full Text] [Related]
8. Breast-feeding is associated with a reduced frequency of acute otitis media and high serum antibody levels against NTHi and outer membrane protein vaccine antigen candidate P6.
Sabirov A; Casey JR; Murphy TF; Pichichero ME
Pediatr Res; 2009 Nov; 66(5):565-70. PubMed ID: 19581824
[TBL] [Abstract][Full Text] [Related]
9. Protein D of Haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines.
Forsgren A; Riesbeck K; Janson H
Clin Infect Dis; 2008 Mar; 46(5):726-31. PubMed ID: 18230042
[TBL] [Abstract][Full Text] [Related]
10. Intranasal coinfection model allows for assessment of protein vaccines against nontypeable Haemophilus influenzae in mice.
Michel LV; Kaur R; Zavorin M; Pryharski K; Khan MN; LaClair C; O'Neil M; Xu Q; Pichichero ME
J Med Microbiol; 2018 Oct; 67(10):1527-1532. PubMed ID: 30136923
[TBL] [Abstract][Full Text] [Related]
11. A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.
Hotomi M; Ikeda Y; Suzumoto M; Yamauchi K; Green BA; Zlotnick G; Billal DS; Shimada J; Fujihara K; Yamanaka N
Vaccine; 2005 Jan; 23(10):1294-300. PubMed ID: 15652672
[TBL] [Abstract][Full Text] [Related]
12. Experimental recurrent otitis media induced by Haemophilus influenzae: protection and serum antibodies.
Melhus A; Hermansson A; Akkoyunlu M; Forsgren A; Prellner K
Am J Otolaryngol; 1995; 16(6):383-90. PubMed ID: 8572254
[TBL] [Abstract][Full Text] [Related]
13. Antibody response to outer membrane protein of nontypeable Haemophilus influenzae in otitis-prone children.
Yamanaka N; Faden H
J Pediatr; 1993 Feb; 122(2):212-8. PubMed ID: 8429433
[TBL] [Abstract][Full Text] [Related]
14. Haemophilus influenzae-protein D specific antibody correlate with protection against acute otitis media in young children.
Almudevar A; Pichichero ME
Vaccine; 2018 Feb; 36(9):1133-1135. PubMed ID: 29395516
[TBL] [Abstract][Full Text] [Related]
15. Lipidation of
Kaur R; Pichichero M
Infect Immun; 2022 May; 90(5):e0067821. PubMed ID: 35435727
[TBL] [Abstract][Full Text] [Related]
16. Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media.
Sabirov A; Kodama S; Hirano T; Suzuki M; Mogi G
Infect Immun; 2001 May; 69(5):2964-71. PubMed ID: 11292713
[TBL] [Abstract][Full Text] [Related]
17. Australian Aboriginal Children with Otitis Media Have Reduced Antibody Titers to Specific Nontypeable Haemophilus influenzae Vaccine Antigens.
Thornton RB; Kirkham LS; Corscadden KJ; Wiertsema SP; Fuery A; Jones BJ; Coates HL; Vijayasekaran S; Zhang G; Keil A; Richmond PC
Clin Vaccine Immunol; 2017 Apr; 24(4):. PubMed ID: 28151410
[TBL] [Abstract][Full Text] [Related]
18. Immunization with outer membrane protein P6 from nontypeable Haemophilus influenzae induces bactericidal antibody and affords protection in the chinchilla model of otitis media.
DeMaria TF; Murwin DM; Leake ER
Infect Immun; 1996 Dec; 64(12):5187-92. PubMed ID: 8945564
[TBL] [Abstract][Full Text] [Related]
19. Impact of protein D-containing pneumococcal conjugate vaccines on non-typeable Haemophilus influenzae acute otitis media and carriage.
Clarke C; Bakaletz LO; Ruiz-Guiñazú J; Borys D; Mrkvan T
Expert Rev Vaccines; 2017 Jul; 16(7):1-14. PubMed ID: 28571504
[TBL] [Abstract][Full Text] [Related]
20. [Mouse macrophage-derived chemokine as an adjuvant enhances the protective effect of P6 protein vaccine of nontypeable Haemophilus influenzae].
Han X; Wang C; Qiao H; Zhang Y; Chang Y; Zhang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Sep; 30(9):913-6. PubMed ID: 25200152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
